Joseph E. Glass, PhD, MSW

Glass_Joseph_E_205x287.jpg

“We need to increase the reach of addiction treatment within health care systems. Many more people could benefit from effective care.”

Joseph E. Glass, PhD, MSW

Associate Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Joe Glass, PhD, MSW, is an associate investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI). Before joining KPWHRI in July 2016, he was an assistant professor at the University of Wisconsin–Madison School of Social Work.

Dr. Glass’ research seeks to understand how effective health care interventions for unhealthy alcohol and drug use can reach more people. His research seeks to answer these questions:

  • Why do so few people receive help for their unhealthy drinking and drug use?
  • How can we change this?
  • How can health systems make better use of effective treatments?
  • In what ways could our current treatments for addiction be improved?
  • Is care for unhealthy alcohol use delivered equitably?

Much of Dr. Glass’ recent work, funded by the National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and Kaiser Permanente, is studying approaches for routinely using smartphone and web-based treatments for unhealthy alcohol and drug use in health care. After receiving an MSW from the University of Michigan, Dr. Glass spent three years as a social worker at the Veterans Affairs Ann Arbor Healthcare System. As a licensed clinical social worker in a large mental health clinic, he developed expertise in social work case management and evidence-based treatments for anxiety, depression, and substance use disorders. Much of his research is driven by his clinical experiences, considering the many people struggling with both mental health difficulties and unhealthy substance use who have yet to receive addiction treatment. 

Dr. Glass is an affiliate assistant professor of health services and of psychiatry and behavioral sciences, at the University of Washington.

Research interests and experience

Recent publications

Frost MC, Glass JE, Bradley KA, Williams EC. Documented brief intervention associated with reduced linkage to specialty addictions treatment in a national sample of VA patients with unhealthy alcohol use with and without alcohol use disorders. Addiction. 2019 Oct 22. doi: 10.1111/add.14836. [Epub ahead of print]. PubMed

Richards JE, Bobb JF, Lee AK, Lapham GT, Williams EC, Glass JE, Ludman EJ, Achtmeyer C, Caldeiro RM, Oliver M, Bradley KA. Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: an evaluation in three pilot sites. Drug Alcohol Depend. 2019 Jun 8;201:134-141. doi: 10.1016/j.drugalcdep.2019.04.015. [Epub ahead of print]. PubMed

Goldberg SB, Simpson TL, Lehavot K, Katon JG, Chen JA, Glass JE, Schnurr PP, Sayer NA, Fortney JC. Mental health treatment delay: a comparison among civilians and veterans of different service eras. Psychiatr Serv. 2019 Mar 7:appips201800444. doi: 10.1176/appi.ps.201800444. [Epub ahead of print]. PubMed

Bensley KM, Fortney J, Chan G, Dombrowski JC, Ornelas I, Rubinsky AD, Lapham GT, Glass JE, Williams EC. Differences in receipt of alcohol-related care across rurality among VA patients living with HIV with unhealthy alcohol use. J Rural Health. 2019 Jan 31. doi: 10.1111/jrh.12345. [Epub ahead of print]. PubMed

Glass JE, Bobb JF, Lee AK, Richards JE, Lapham GT, Ludman E, Achtmeyer C, Caldeiro RM, Parrish R, Williams EC, Lozano P, Bradley KA. Study protocol: a cluster-randomized trial implementing Sustained Patient-centered Alcohol-related Care (SPARC trial). Implement Sci. 2018;13(1):108. doi: 10.1186/s13012-018-0795-9. PubMed

 

innovating care

Cannibus-use-Gwen-Lapham-blog_1col.jpg

Asking patients about cannabis may benefit overall health

Drs. Lapham and Bradley find frequency of cannabis use can be tied to other behavioral health patterns and needs.

opioids

opioids-doctor-patient-trust_sherman-post_1-col-20180709.jpg

Patient-doctor trust withstands opioid risk reduction

Risk-reduction initiative for chronic opioid therapy sustains patient-doctor trust, Dr. Karen Sherman finds.